Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Iradimed (IRMD) EBT Margin (2016 - 2025)

Historic EBT Margin for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to 34.42%.

  • Iradimed's EBT Margin fell 6000.0% to 34.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 33.43%, marking a year-over-year increase of 3100.0%. This contributed to the annual value of 33.14% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's EBT Margin is 34.42%, which was down 6000.0% from 35.9% recorded in Q2 2025.
  • In the past 5 years, Iradimed's EBT Margin ranged from a high of 38.83% in Q3 2023 and a low of 18.93% during Q2 2021
  • Moreover, its 5-year median value for EBT Margin was 31.64% (2022), whereas its average is 30.49%.
  • As far as peak fluctuations go, Iradimed's EBT Margin surged by 617800bps in 2021, and later crashed by -38100bps in 2024.
  • Over the past 5 years, Iradimed's EBT Margin (Quarter) stood at 26.22% in 2021, then rose by 21bps to 31.64% in 2022, then rose by 3bps to 32.56% in 2023, then rose by 1bps to 32.72% in 2024, then grew by 5bps to 34.42% in 2025.
  • Its EBT Margin was 34.42% in Q3 2025, compared to 35.9% in Q2 2025 and 30.47% in Q1 2025.